Navigation Links
"Pre-treatment Blood Test" A New Guide to Lung Cancer Therapy

llaborators providing patient samples, set out to determine if a protein profile in the peripheral blood could predict clinical benefit measured in terms of patient survival to EGF receptor TKIs.

Using mass spectrometry, the researchers analyzed pre-treatment blood samples from 139 patients who had been treated with gefitinib (three patient cohorts in Italy and Japan), identified a pattern of eight proteins that was correlated with survival, and developed a prediction algorithm. They then tested the algorithm in two additional groups of patients 67 gefitinib-treated patients in Italy and 96 erlotinib-treated patients in a U.S. Eastern Cooperative Oncology Group protocol. At the time of the mass spectrometry analysis and classification, the researchers were blind to the survival status of the patients.

We classified the patients as being either likely to benefit (good) or not likely to benefit (poor) from the TKIs, Carbone said. The method was highly successful in predicting a survival benefit. In the gefitinib-treated group, patients classified as good had a median survival of 207 days whereas those classified as poor had a median survival of 92 days. In the erlotinib-treated group, median survivals for good and poor groups were 306 and 107 days, respectively.

The fact that the signature, which was developed from gefitinib-treated patients, also accurately predicted a survival benefit for erlotinib-treated patients buoys Carbones confidence in the algorithm, he said, since these two drugs share a common mechanism of action. The method was not prognostic it did not predict a survival benefit in three different control groups of patients treated with either chemotherapy or surgery alone.

The investigators are currently working with the Eastern Cooperative Oncology Group to develop a prospective national phase III trial that will test the prediction methods clinical benefit in lung cancer patients who are just
'"/>




Page: 1 2 3

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pre treatment Blood Test New Guide Lung Cancer Therapy

(Date:12/26/2014)... 26, 2014 Cooking and warming ... out of 5. This score reflects slightly positive negotiation ... product specialization, low switching costs and a low level ... the low availability of substitutes for cooking and warming ... steel and aluminum, key inputs in the production process ...
(Date:12/26/2014)... 26, 2014 Plugin and template developers from ... 5 Plugin for Final Cut Pro X. , “TransPack Volume ... tool to pull off an industry professional look” Said Christina ... hands on TransPack Volume 5, a new level of professionalism ... set of over 50 Final Cut Pro X transitions featuring ...
(Date:12/26/2014)... 26, 2014 Pentec Health, Inc. number ... state of Pennsylvania for 2014. The awards program, created ... of its kind in the country. The program is ... Department of Community and Economic Development, the Pennsylvania State ... the Central Penn Business Journal. , Charlie ...
(Date:12/25/2014)... The microscopy market is estimated ... reach $5,756.0 million by 2019. Optical microscopy is ... electron microscopes product segment is expected to show ... Rising focus on nanotechnology, technological advancements, and increasing ... market. , Get Full Copy of Report @ ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... Analysis to 2023” focuses on the current treatment ... in the colorectal cancer market. Stivarga is a ... colon or rectal cancer. Boehringer Ingelheim is developing ... the treatment of refractory CRC in the US, ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... OAK BROOK, Ill., April 22 The ... of Minnesota have agreed to conditions for ... receive certain services from DeCare Dental following ... certain business functions that DeCare previously performed ...
... patient medical bill clearinghouse is set to help more than 50 ... patient medical debt. IOUSOS™, Powered by GlobeFunder and GlobalTech Collection ... way to deal with aged, unpaid patient bills now totaling an ... ...
... of Driver Technology to Power Artificial Heart Presented at ISHLT ... ... (Vocus) April 22, 2009 -- On April 22-25, SynCardia Systems, ... introduced the new 12-lb Freedom™ discharge driver at the International ...
... Illinois-based leader in physical therapy, fitness, and performance services, recently reached ... Chicago,s Hyde Park neighborhood and 51st center in suburban Naperville. ... ... AthletiCo , an Illinois-based leader in physical therapy, fitness, ...
... clinical supply chain management, announced today that Daniel C. Lubin, a Managing ... www.mhsinc.com , ... Fairfield, Connecticut (PRWEB) April 22, 2009-- ... clinical supply chain management, announced today that Daniel C. Lubin, a Managing ...
... to providing people with skin care information from ... and helpful insights are provided by skin care ... cosmetic dermatology. The content is written by experts ... of practical advice. Key portions of the service ...
Cached Medicine News:Health News:Delta Dental Plans Association and Delta Dental of Minnesota Agree to Conditions Regarding Supplier 2Health News:IOUSOS™ Launches Online Consumer Medical Bill Clearinghouse: New Service Set to Help More than 50 Million Americans and Healthcare Providers 2Health News:IOUSOS™ Launches Online Consumer Medical Bill Clearinghouse: New Service Set to Help More than 50 Million Americans and Healthcare Providers 3Health News:IOUSOS™ Launches Online Consumer Medical Bill Clearinghouse: New Service Set to Help More than 50 Million Americans and Healthcare Providers 4Health News:SynCardia Introduces New 12-lb Freedom Discharge Driver ,Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients 2Health News:Illinois-Based AthletiCo Opens Milestone 50th Physical Therapy Center 2Health News:Illinois-Based AthletiCo Opens Milestone 50th Physical Therapy Center 3Health News:Daniel C. Lubin Joins Management Health Solutions, Inc. Board of Directors 2Health News:Beauty-Doctors Website Provides Dermatologist-Authored Skin Care Information from Experts 2
(Date:12/24/2014)... DALLAS , Dec. 23, 2014  Lockton ... operation of Lockton Companies, announced the addition of ... Foerster will join Lockton Dunning,s Pharmacy Consulting team, ... years of relevant industry experience to the position.  ... Managed Market Sales at Diplomat Specialty Pharmacy, where ...
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/24/2014)... and RALEIGH, N.C. , ... of Endo International plc (NASDAQ: ENDP ) ... BDSI ) announced today that they have submitted ... Film to the U.S. Food and Drug Administration (FDA).  ... management of pain severe enough to require daily, around-the-clock, ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... Core Essence Orthopaedics, Inc., a medical device company ... the extremities, has introduced their novel, surgeon-designed PONTiS™ Knotless ... the American Society for Surgery of the Hand (ASSH). ... to the upper and lower extremity markets, Core Essence ...
... 9, 2011 The Board of the European ... it agreed to ratify the proposal of the US Food ... designed with the help of EFCG and US industry representatives, ... Fees Act (GDUFA). GDUFA requires the FDA to ...
Cached Medicine Technology:Core Essence Orthopaedics Unveiled New Flexor Tendon Repair System at ASSH 2011 2European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA) 2
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
Medicine Products: